Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

Lantheus shares fell 25% post-Q1 2025 report due to disappointing EPS guidance and not meet analysts' expectations. Click ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United States — but why are drugs so high to begin with?

Donald Trump's executive order targeting international consumer price parity for prescription drugs in the US faces implementation challenges and potential legal battles. While unlikely to ...

Trumps most favoured nation drug policy would negatively impact many Indian pharma companies On Monday, US President Donald Trump signed a new executive order reviving the controversial ‘Most Favored ...

Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...

President Trump said in a new interview that the pal who inspired a viral "fat shot" anecdote Trump told while unveiling his ...

In addition to Welch, Merkley, Sanders, and Dingell, the End Price Gouging for Medications Act is co-sponsored by U.S. Senator Dick Durbin (D-IL). The bicameral bill is endorsed by Public Citizen, ...

Drug companies—and innovation—will suffer thanks to Trump’s executive order.

European governments are examining whether US President Donald Trump can force them to pay more for prescription medicines, ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...